Navigating Histopathology Grey Zones: A Medicolegal Framework for Breast Pathology in the AI Era

This paper proposes a conceptual framework designed to assess histopathological diagnoses, particularly in complex 'grey zone' cases, from a medicolegal perspective. It acknowledges that traditional retrospective reviews by subspecialist experts can be influenced by hindsight and knowledge of clinical outcomes, potentially setting unrealistic expectations for the original reporting pathologist. The framework is built upon three fundamental principles: ensuring reasonable competence aligned with the professional role, considering the diagnostic context prevalent at the time the report was issued, and recognizing the inherent, well-documented variability within histopathological interpretation. The proposed contextual diagnostic standard moves beyond seeking a singular, 'perfect' diagnosis in hindsight. Instead, it advocates for recognizing a spectrum of acceptable interpretations that would be supported by a responsible body of comparably competent practitioners operating under similar conditions. This approach is critical as AI tools begin to augment diagnostic processes, potentially introducing new layers of interpretative challenge and necessitating a robust framework for evaluating human and AI-assisted performance.

For practicing pathologists, surgical oncologists, and healthcare administrators, this framework is crucial for mitigating medicolegal risks associated with diagnostic variability, especially in an era of rapid technological advancement and increasing AI integration. It provides a more equitable and realistic standard for evaluating diagnostic accuracy, moving away from an often-unachievable 'perfect' diagnosis toward a 'reasonable' one. This can help reduce professional anxiety and provide clearer guidelines for expert witness testimony. Implementing such a framework can enhance the defensibility of clinical decision-making and foster more consistent expert opinions in retrospective case reviews. By aligning medicolegal assessments with the practical realities of contemporary pathology practice, it aims to prevent situations where a pathologist's original diagnosis, made under specific contextual constraints, is unfairly judged against an idealized, hindsight-informed benchmark. This is particularly relevant as AI systems offer 'optimal' interpretations, potentially creating a new benchmark that needs to be reconciled with human diagnostic variability.

Practicing pathologists should familiarize themselves with this contextual diagnostic framework to better understand the evolving standards of care, especially as AI tools become more prevalent. Department heads should consider integrating these principles into quality assurance protocols and medicolegal preparedness training. When collaborating with AI diagnostic aids, clinicians should document the contextual information influencing their final diagnoses to provide a robust defense against potential retrospective challenges. This framework supports a nuanced understanding that even with AI assistance, human interpretative variability within a 'reasonable' range remains a critical component of medical practice.

While highly relevant, this article presents a conceptual framework rather than an empirical study with quantitative outcomes. The efficacy of its implementation in real-world medicolegal cases still needs to be empirically validated. Defining 'reasonable competence' and 'comparable conditions' across diverse institutions and varying levels of subspecialization may prove challenging. Furthermore, the framework's adaptability to future AI advancements, which may achieve super-human diagnostic capabilities in specific tasks, and the subsequent impact on the 'reasonable pathologist' standard, remains to be seen. The generalizability beyond breast pathology, while intended, would require further specific validation.